Humam Kadara - Concepedia

Author

Humam Kadara

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Brendan J. Jenkins, H Kadara, H. Kadara, HUMAM KADARA, Harvey Pass, Humam Kadara, Humam N Kadara, Humam N. Kadara, Ignacio Wistuba, Kadara, H.

514

Publications

10.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center American University of Beirut The University of Texas Health Science Center at Houston The University of Texas Southwestern Medical Center Nagasaki University

About

Humam Kadara is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, lung cancer, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	2.2K
2	Cell Biology	11	11	1.1K
3	Immunology	8	8	1K
4	Engineering	3	3	217
5	Health Sciences	2	2	73

Humam Kadara

102

Publications

8.6K

Citations

H-Index

Page 1

	Year	Citations
Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities Ferdinandos Skoulidis, Lauren A. Byers, Lixia Diao, Cancer Discovery	2015	883
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial Tina Cascone, William N. William, Annikka Weissferdt, Nature Medicine Neostar TrialMedicineImmune Checkpoint InhibitorCancer TreatmentPhase 2	2021	582
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Yanshuo Chu, Enyu Dai, Yating Li, Nature Medicine Cancer ImmunosurveillanceT-regulatory CellImmunologyTumor ImmunityImmunoediting	2023	418
Ursolic Acid Inhibits STAT3 Activation Pathway Leading to Suppression of Proliferation and Chemosensitization of Human Multiple Myeloma Cells Ashutosh Pathak, Manisha Bhutani, S. Asha Nair, Molecular Cancer Research	2007	234
Comprehensive T cell repertoire characterization of non-small cell lung cancer Alexandre Reuben, Jiexin Zhang, Shin-Heng Chiou, Nature Communications	2020	221
IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras–Mutant Lung Cancer Mauricio S. Caetano, Huiyuan Zhang, Amber M. Cumpian, Cancer Research	2016	215
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy Guangchun Han, Guoliang Yang, Dapeng Hao, Nature Communications	2021	208
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up Humam Kadara, Murim Choi, J. Zhang, Annals of Oncology	2016	207
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt, Nature Medicine	2023	191
ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer Mohamed Kabbout, Melinda Garcia, Junya Fujimoto, Clinical Cancer Research	2013	190

Page 1